R3TA– 30mg
R3TA is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 30mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
R3TA is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 30mg vial
– ≥99% purity
– Lyophilized powder
– For research use only

